Last update 01 Nov 2024
Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.

Private Company|
2007|
Beijing Shi, China

Overview

Tags

Skin and Musculoskeletal Diseases
Infectious Diseases
Otorhinolaryngologic Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Immune System Diseases1
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug3
Top 5 TargetCount
Bcr-Abl(Bcr-Abl tyrosine kinase)1
SCNA(Sodium voltage-gated channel alpha subunits)1
Ergosterol1

Related

3
Drugs associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
Ambroxol Hydrochloride
Target
SCNA
Mechanism
SCNA modulators
Active Org.
Shanxi Yanghe Pharmaceutical Technology Co., Ltd. [+32]
Originator Org.
Teijin Pharma Ltd.
Active Indication
Chronic sinusitis [+22]
Inactive Indication
Acute pharyngitis
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date27 May 1983
Fenticonazole Nitrate
Target
Ergosterol
Mechanism
Ergosterol biosynthesis inhibitors
Active Org.
Nanjing Haina Pharmaceutical Technology Co Ltd.Nanjing Haina Pharmaceutical Technology Co Ltd. [+3]
Originator Org.-
Active Indication
Mycoses [+3]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.-
First Approval Date-
Meditinib Sulfate
Target
Bcr-Abl
Mechanism
Bcr-Abl inhibitors
Active Org.
Harbin Gloria Pharmaceuticals Co., Ltd.Harbin Gloria Pharmaceuticals Co., Ltd. [+2]
Originator Org.
Harbin Gloria Pharmaceuticals Co., Ltd.Harbin Gloria Pharmaceuticals Co., Ltd.
Active Indication
Philadelphia chromosome positive chronic myelogenous leukemia
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
4
Clinical Trials associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
CTR20130250 / Active, not recruitingPhase 1
硝酸芬替康唑栓临床药代动力学试验
[Translation] Clinical Pharmacokinetics of Fenticonazole Nitrate Suppositories
CTR20160429 / RecruitingPhase 1
硫酸美迪替尼片在初治慢性髓系白血病慢性期受试者中单次给药剂量递增Ⅰ期临床试验
[Translation] Phase I clinical trial of single-dose escalation of Meditinib sulfate tablets in subjects with chronic phase chronic myeloid leukemia who were previously untreated
CTR20130309 / Active, not recruitingPhase 2
评价硝酸芬替康唑栓的有效性和安全性的多中心、随机、盲法、阳性药物平行对照II期临床试验
[Translation] A multicenter, randomized, blinded, positive drug parallel controlled phase II clinical trial to evaluate the efficacy and safety of fenticonazole nitrate suppositories
100 Clinical Results associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
Login to view more data
100 Deals associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Meidi Kangxin Pharmaceutical Technology Co.,Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Phase 2 Clinical
Phase 3 Clinical
1
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free